When non-surgical options fail
The iFuse Implant System was developed as a minimally invasive surgical option for patients who have failed non-surgical options. Over the last several years more than 18,000 procedures have been performed and over 1,000 surgeons have been trained to provide this option for their patients. This section includes information on the iFuse Implants, the surgical procedure, and clinical results.
The iFuse Implant System is intended for sacroiliac fusion for conditions including sacroiliac joint dysfunction that is a direct result of sacroiliac joint disruption and degenerative sacroiliitis. This includes conditions whose symptoms began during pregnancy or in the peripartum period and have persisted postpartum for more than 6 months. Clinical studies have demonstrated that treatment with the iFuse Implant System improved pain, patient function, and quality of life at 12 months post-implantation. There are potential risks associated with the iFuse Implant System. It may not be appropriate for all patients and all patients may not benefit. For information about the risks, visit: www.si-bone.com/risks